Table 5.

Changes from baseline in cardiovascular risk factors for participants with baseline C-reactive protein > 4 mg/l (Mean values with their standard errors)

Parameters	Sample size (cranberry/placebo)	Cranberry		Placebo		P *
		Mean	se	Mean	se
Weight (kg)	10/7	−0·83	0·57	0·40	0·68	0·19
Systolic BP (mmHg)	10/7	5·80	2·3	2·86	2·75	0·43
Diastolic BP (mmHg)	10/7	0·10	2·34	−3·71	2·8	0·31
Glucose disposal rate (mg/kg × min)	10/7	−0·39	0·35	0·44	0·42	0·15
Fasting glucose (mmol/l)	10/7	0·03	0·10	−0·06	0·12	0·62
2-h glucose (mmol/l)	10/7	−0·32	0·44	−0·63	0·53	0·66
RHI from EndoPAT	10/7	−0·17	0·19	−0·12	0·22	0·86
RMR	10/7	−9·5	42·7	−97·29	51·04	0·21
Total cholesterol (% change)	10/7	−14·1	2·67	−11·60	3·19	0·56
LDL (% change)	10/7	−13·55	2·89	−11·63	3·46	0·68
HDL (% change)	10/7	−16·32	2·51	−20·09	3	0·35
TAG (% change)	10/7	−13·75	6·8	10·32	8·13	0·04

BP, blood pressure; RHI, reactive hyperaemia index.

^*P values are for between-group differences.